Q&A (CCC-201)

Saturday, October 28, 2023

15:46 – 16:00 EST

Location: Palais, 520A-F

Target Audience: Critical care practitioners, Community cardiologists, Trainee (clinical)

Chair(s)

Sean van Diepen, MD, MSc

Physician
University of Alberta
University of Alberta

Co-Chair(s)

Christopher Brian Overgaard, MD, MSc., FRCPC (he/him/his)

Director, Interventional and Complex PCI Program, Southlake Regional Healthcare Centre
ccs
CANCARE

Presenter(s)

Craig Ainsworth, MD FRCPC (he/him/his)

Associate Professor of Medicine
CANCARE
McMaster University
Eitan Aziza, MD, FRCPC (he/him/his)

Resident
University of Alberta
University of Alberta
Emilie P. Belley-Cote, MD

EARLY CAREER
CCS, CANCARE
McMaster Unviersity
Andrew Caddell, MD, MSc, FRCPC

Cardiac Intensivist
CANCARE, CCTN
Dalhousie University
Andrea L. Daly (she/her/hers)

Cardiologist/Cardiac intensivist
Trillium Health Partners
University of Toronto
Michael Goldfarb, M.D., M.Sc.

Cardiac Intensivist
CANCARE
McGill University
Jordan H. Hutson

Critical Care Cardiologist
University of Ottawa Heart Institute
University of Ottawa Heart Institute
Rebecca Mathew, MD FRCPC

Critical Care Cardiologist
University of Ottawa Heart Institute
University of Ottawa Heart Institute
PR

Penelope Rampersad, MD, MSc, FACC, FRCPC

Staff Cardiologist
Cleveland Clinic
ER

Erin Rayner-Hartley, MD, FRCPC

Cardiology, Critical Care Medicine
CANCARE
University of British Columbia
Thomas M. Roston MD PhD, FRCPC

Genetic & Critical Care Cardiologist
Univ British Columbia
University of British Columbia

Panelist(s)

PL

Patrick R. Lawler, MD, MPH, FRCPC

Associate Professor
CANCARE
MP

Maude Peretz-Larochelle, MDCM, FRCPC

Adult Cardiologist and Critical Care Medicine Specialist
CANCARE
McGill University
Gurmeet Singh, MD, MSc, FRCSC

Critical Care & Cardiac Surgery
CANCARE & CSCS
CANCARE, CSCS

Disclosure(s):

Michael Goldfarb, M.D., M.Sc.: No financial relationships to disclose

Gurmeet Singh, MD, MSc, FRCSC: Abbott Laboratories: Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing)

Learning Objectives / Objectifs d'apprentissage:

At the end of this session participants will be able to / Au terme de cette conférence, vous serez:

evaluate whether hydrocortisone should be routinely used in critically ill patients with pneumonia;
identify the strength and limitations of a trial examining whether early mobilization improves survival and ventilator free days in patients receiving mechanical ventilation;
critically appraise whether high protein feeds should be used in critically ill patients;
evaluate if double sequential defibrillation should be incorporated into clinical practice for refractory VF; and
incorporate the results of the ECMO-CS and ELCS shock trials into your care of patients with cardiogenic shock.

Workshop Description: In a fast-paced presentation workshop format, 5 trainees (or junior attendings in their first year of clinical practice) will be paired with 5 practicing intensivists to review the top 5 ICU trials published in the last year. Each trainee will present a brief 1.5-minute Cardiovascular Intensive Care Unit (CICU) case that highlights the potential impact of the major ICU clinical trial on CICU practice. The senior cardiac intensivists will provide a brief overview of the trial and discuss the applicability of the trial to CICU patient care. Both the junior and senior faculty will participate in the audience question and answer period.